Pascale Witz is the President and Chief Executive Officer of GE Healthcare’s Medical Diagnostics business (MDx), and an officer of the General Electric Company.

MDx is a $2B global leader in diagnostic imaging agents, with nearly 5,000 employees dedicated to creating, manufacturing and marketing high-quality contrast media and molecular imaging agents, including Visipaque™, Omnipaque™, Omniscan™, Myoview™, AdreView™, DaTSCAN™, and Hexvix™.

Pascale joined GE Healthcare in 1996, and has served successfully in a number of senior management roles, including leading the Functional Imaging (Nuclear Medicine and PET) business in EMEA, and the CT (Computed Tomography) business in EMEA. Prior to her current role, she was in charge of the global Interventional business, a $700M business unit that develops innovative medical technologies for interventional radiology and cardiology.

Prior to joining GE, Pascale worked in a molecular biology research laboratory, and spent five years in the pharmaceutical industry.

Pascale has been an active leader in the GE Women's Network for some years and now serves on the executive board. The GE Women's Network boasts a membership of over 180,000 women globally with a goal of focusing on the professional development of women throughout the company.

Pascale holds a Masters degree in life sciences/molecular biology from INSA Lyon, and an MBA from INSEAD.